Jeanny aragon-ching
WebJan 21, 2024 · Dr. Jeanny Aragon-Ching is the clinical program director of genitourinary cancers within the Inova Schar Cancer Institute. Dr. Jeanny B. Aragon-Ching has received an honoraria from Bristol-Myers Squibb. She has a consulting or advisory role with Algeta/Bayer, Dendreon, AstraZeneca, Janssen Biotech, and Sanofi. ... WebDr. Jeanny B. Aragon-Ching is an Internal Medicine Doctor in Fairfax, VA with special training and skill in the diagnosis, treatment, and care of adults across the spectrum from …
Jeanny aragon-ching
Did you know?
WebUroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology. WebNov 20, 2024 · Jeanny B. Aragon-Ching, MD, FACP Author Bios Disclosures Dr. Jeanny B. Aragon-Ching Article Highlights Apalutamide, enzalutamide, and darolutamide are all novel antiandrogens that have been shown to improve metastasis-free survival, and all are approved by the FDA for nmCRPC.
WebMay 15, 2024 · Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Prostate cancer is an extremely common ... WebJeanny Aragon-Ching Clinical Program Director of Genitourinary Cancers at Inova Schar Cancer Institute Fairfax County, Virginia, United States 232 …
WebSep 21, 2024 · Jeanny B. Aragon-Ching, MD, FACP, clinical program director, Genitourinary Cancers, the Inova Schar Cancer Institute, discusses the clinical implications of the phase 3 JAVELIN Bladder 100 ... WebJeanny B. Aragon-Ching, M.D. Dr. Aragon-Ching is a specialty Oncology care physician board certified in medical oncology, hematology and internal medicine. She joins Inova …
Web, Jeanny B Aragon-Ching 4 Affiliations 1Virginia Commonwealth University, Department of Hematology, Oncology and Palliative Car. 2Inova Fairfax Hospital, Department of Internal …
WebJeanny B Aragon-Ching Maintenance therapy with immune checkpoint inhibitors (ICIs) has changed the treatment paradigm of metastatic urothelial carcinoma (mUC). The JAVELIN … teach for polandWebMar 4, 2024 · Plasmacytoid variant of urothelial carcinoma is a rare subtype of urothelial carcinoma that has poor prognosis. We describe two cases of patients with the plasmacytoid variant of urothelial carcinoma (PVUC) who had initial response to neoadjuvant chemotherapy followed by radical cystoprostatectomy and lymph node … teachforqatar.orgWebJun 18, 2024 · Dr. Aragon-Ching is a medical oncologist and the clinical program director of the Genitourinary Oncology Program at the Inova Schar Cancer Institute in Virginia. Our full disclosures are available in the show … south in welshWebJeanny B. Aragon-Ching; Inger L. Rosner; Translational Andrology and Urology. Published on 01 Oct 2024. 0 views XX downloads; XX citations; 1760P Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Results from patients with ≥12 mo of treatment in JAVELIN Bladder 100. J.B. Aragon-Ching ... south iowa juvenile detention centerWebJun 21, 2024 · Campbell Siefker-RadtkeAO. Optimizing management uppertract urothelial cancers. Urologic Oncol 2024;35:492–8. [13] Bagheri AhlmanMA, Lindenberg etal. Advances medicalimaging commongenitourinary cancers. Urolo Oncol 2024;35:473–91. J.B. Aragon-Ching UrologicOncology: Seminars OriginalInvestigations 35 (2024) 462–464 464 south in ya mouth food truckWebSep 8, 2024 · Dr. Jeanny Aragon-Ching, MD is a hematology specialist in Fairfax, VA. Dr. Aragon-Ching completed a residency at Albert Einstein Medical Center. She currently … south iredell athletic associationWebFeb 8, 2024 · Jeanny B. Aragon-Ching, MD, FACP Advanced Urothelial Carcinoma February 8, 2024 Dr. Aragon-Ching offers her thoughts on whether metastatic bladder cancer lends … teach for qatar 2022